Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2025-11-05 00:00:00 ET · period of report 2025-11-03 · accession 0001193125-25-267057 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-05 | 2025-11-03 | PHAT | Breedlove Robert Charles | Principal Accounting Off | S - Sale | $13.51 | -524 | 47.4K | -1% | -$7,079 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-03 | S | D | 524 | $13.51 | 47,407 | D | — | — |